TGX.NYSE 10X Genomics Trend Cloud Study Potential 100% Upside.
10X Genomics Trend Cloud Study shows a Potential 100% Upside.
This Ticker is way oversold and a Double Bottom is Seen.
Very Risky and Speculative. I'm Nibbling a few $100.
As always, please get a few outside Expert's Advice before making Trade or Investment Decisions.
Should you appreciate my Chart Studies, Smash That Rocket Boost Button. It's Just a Click away.
Regards Graham.
This Ticker is way oversold and a Double Bottom is Seen.
Very Risky and Speculative. I'm Nibbling a few $100.
As always, please get a few outside Expert's Advice before making Trade or Investment Decisions.
Should you appreciate my Chart Studies, Smash That Rocket Boost Button. It's Just a Click away.
Regards Graham.
Заметка
As normal will need a Catalyst OR RISK ON Sentiment. As Said I'm nibbling on this one. Should there be a FED rate Cut the down Momentum will Reverse IMO. I'm currently in a small loss scenario - however it's important to be patient and try not to destroy ones Capital. I'm Holding for Now and will watch till a potential Rate Cut.Заметка
Holding for now. Has performed worse than anticipated. Conviction is Required.
Заметка
On My Chart this on a Wave -9 Down.Due for a reversal soon as very oversold.
However my strategy is WAIT.
Заметка
Buy.Canaccord Genuity Adjusts Price Target on 10x to $32 From $50, Maintains Buy Rating.
Заметка
The Japanese Carry Trade Has Distorted Many Stocks and Trades.
I did Dip Buy a Few $ in anticipation.
Заметка
10x Genomics Executives Sell Shares to Cover their Tax Obligations.
Paying Tax via Share Options is normal and expected.
Holding.
Заметка
10x Genomics Price Target Announced at $35 a Share by Leerink Partners.Заметка
10x Genomics Price Target Maintained With a $30 a Share by Stephens & Co.
Volatile Markets.
Difficult to buy now. but Holding.
Заметка
Remember to always set your Stop Loss at a reasonable value to maintain ones capital. Adobe is an example.Заметка
Gene Sequencing Tech Provider 10x Genomics' Q3 Sales Fall Short On Expectations, But CEO Sees Opportunity Ahead. Shares Tank.Заметка
Nasty One.
10x Genomics Price Target Cut to $20 a Share From $32 by Canaccord Genuity.
Canaccord Genuity now moved Down on my Ranking to 30% Reliable. Which is Useless IMO.
Сделка активна
Recent JFKJ to Health Minister by Trump and his Stance on Vaccines shows a sell.
I'm Out.
Сделка закрыта: достигнута тейк-профит цена
I could start to nibble, based on activists convincing JFK about VACs. Заметка
Whilst this Ticker is not a VAC stock, there is sympathy trades.Заметка
Re- enter with a small position.
Отказ от ответственности
Все виды контента, которые вы можете увидеть на TradingView, не являются финансовыми, инвестиционными, торговыми или любыми другими рекомендациями. Мы не предоставляем советы по покупке и продаже активов. Подробнее — в Условиях использования TradingView.